I was born in Vermont and graduated from the University of Vermont (UVM) with BS in medical technology. During the Vietnam War, I was drafted into US Army where I served as a Medical Lab Specialist at Fort Dix, Fort Sam Houston, Fort Sheridan and the US Public Health Clinic in Chicago.
Upon honorable discharged from the Army, I completed a Master of Science degree in botany with a focus in phycology and cell biology from UVM. I continued working in Medical Center Hospital of Vermont Clinical Laboratory as the Supervisor of Clinical Immunology while completing a Master of Education degree in foundations of education at UVM. Upon graduation with the M.Ed., I accepted an Assistant Professor position in the Department of Medical Laboratory Sciences at the University of Illinois (Medical Center) where I taught immunology and several other components of laboratory science while completing a PhD at Rush University in the Department of Immunology. I also had a part-time position as supervisor of the hematology lab at the 1,000-bed Rush-Presbyterian-St. Luke’s Medical Center (now Rush University Medical Center).
Upon completing my PhD, I was offered a position at Abbott Laboratories in the Abbott Diagnostics Division. There I worked on numerous products involving tests for allergy, cancer, and infectious diseases including strep throat and HIV, and 15 consumer diagnostics. In addition to tests, I evaluated numerous Abbott diagnostic instruments.
From Abbott I was recruited to Bristol-Myers Squibb (BMS) where I served as a Global Marketing Research Manager for infectious diseases and cancer, and then Global Product Manager for cancer products including TAXOL®. Subsequent to pharmaceuticals, I moved to Director of Corporate Marketing Research involving medical devices and consumer products, which led to involvement in mergers and acquisitions and corporate consulting, where I worked with such companies as Boston Consulting, McKinsey, AD Little, Navigant, Medical Data International, Goldman Sachs, Morgan Stanley, Merrill Lynch and JP Morgan.
From BMS I moved to Pharmacia in the oncology pharmaceuticals group and when Pfizer acquired Pharmacia I returned to BMS in as the Director of oncology licensing. As the Director of oncology licensing, I evaluated nearly 250 new compounds, products and ideas per year from nearly as many companies. I monitored several development programs including the TAXOL® synthesis project from Florida State University for five years. Notable projects and companies in which I was involved included ImClone, Medarex, National Institute of Health and Nerviano Medical Sciences. Then I moved to Florida.
Currently, I am a Professor III of Biology, Microbiology and Biotechnology at Palm Beach State College teaching biology 1 and 2 for majors, microbiology and introduction to biotechnology. I also teach a graduate course in biotechnology business at Florida Atlantic University in the Biology and Business departments. At Palm Beach Atlantic University, I guest lecture in pharmacology for rheumatoid arthritis and have participated in several courses for immunology, biotechnology, transplantation, and infectious diseases all in the Gregory School of Pharmacy. Finally, I guest lecture in Nova Southeastern University’s graduate pharmacy program on the role of marketing research in the pharmaceutical industry.
However, since I like school, I am also enrolled in the University of Florida on line program to receive a certificate in pharmaceutical chemistry.
I am the Biology Cluster Chairperson at PBSC, the faculty advisor to the PBSC Pre-Pharmacy Club and for the fall of 2017, I am the Interim Department Chairperson for the PBSC Environmental Sciences Program.
That is my story, so far.